KK
Kanchan Kumar Ghosal
About Kanchan Kumar Ghosal
Data last updated:
Kanchan Kumar Ghosal is a Director at Drakt Pharmaceuticals Pvt Ltd (since 1994). The company operates in Pharma. Drakt Pharmaceuticals Pvt Ltd reported revenue of ₹5.75 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Drakt Pharmaceuticals Pvt Ltd U24232WB1993PTC058790 | Director | 28 Sep 1994 | 1993 | ₹5.75 Cr (FY 2019) | Active |
Board colleagues of Kanchan Kumar Ghosal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bibhas Saha | 05290929 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Jiban Kumar Saha | 02496761 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Pabitra Ranjan Chakraborty | 05295748 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Rana Dasgupta | 01849578 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Sanjoy Kumar Paul | 05290953 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Subhash Roychowdhury | 01852494 | Drakt Pharmaceuticals Pvt Ltd | Director |
| Swapan Kumar Saha Roy | 02347410 | Drakt Pharmaceuticals Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanchan Kumar Ghosal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanchan Kumar Ghosal
Kanchan Kumar Ghosal currently holds 1 directorship: Drakt Pharmaceuticals Pvt Ltd (Director, since 28 Sep 1994, revenue ₹5.75 Cr (FY 2019)).
Kanchan Kumar Ghosal was first appointed on 28 Sep 1994 as Director at Drakt Pharmaceuticals Pvt Ltd.
The current boards of Kanchan Kumar Ghosal's companies include Bibhas Saha (Drakt Pharmaceuticals Pvt Ltd), Jiban Kumar Saha (Drakt Pharmaceuticals Pvt Ltd), Pabitra Ranjan Chakraborty (Drakt Pharmaceuticals Pvt Ltd), Rana Dasgupta (Drakt Pharmaceuticals Pvt Ltd), Sanjoy Kumar Paul (Drakt Pharmaceuticals Pvt Ltd), Subhash Roychowdhury (Drakt Pharmaceuticals Pvt Ltd), among others.